LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 45.25 | 84.90 | 981 | 4539 | 0.2161 | 0.5315 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 45.25 | 84.90 | 1015 | 4539 | 0.2236 | 0.5407 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 45.25 | 84.90 | 74 | 4539 | 0.0163 | -0.0236 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 45.25 | 84.90 | 1226 | 4539 | 0.2701 | 0.5922 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 46.95 | 84.90 | 972 | 4952 | 0.1963 | 0.5153 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 46.95 | 84.90 | 1008 | 4952 | 0.2035 | 0.5247 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 46.95 | 84.90 | 85 | 4952 | 0.0172 | 0.0002 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 46.95 | 84.90 | 1235 | 4952 | 0.2494 | 0.5784 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 48.65 | 84.90 | 1031 | 5328 | 0.1935 | 0.5191 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 48.65 | 84.90 | 1064 | 5328 | 0.1997 | 0.5271 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 48.65 | 84.90 | 75 | 5328 | 0.0141 | -0.0205 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 48.65 | 84.90 | 1261 | 5328 | 0.2366 | 0.5712 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 50.36 | 84.90 | 1049 | 5651 | 0.1856 | 0.5145 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 50.36 | 84.90 | 1073 | 5651 | 0.1899 | 0.5202 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 50.36 | 84.90 | 85 | 5651 | 0.0150 | 0.0002 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 50.36 | 84.90 | 1240 | 5651 | 0.2194 | 0.5569 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 52.06 | 84.90 | 1068 | 5990 | 0.1783 | 0.5103 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 52.06 | 84.90 | 1092 | 5990 | 0.1823 | 0.5158 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 52.06 | 84.90 | 95 | 5990 | 0.0159 | 0.0185 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 52.06 | 84.90 | 1243 | 5990 | 0.2075 | 0.5481 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 53.77 | 84.90 | 1063 | 6252 | 0.1700 | 0.5030 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 53.77 | 84.90 | 1091 | 6252 | 0.1745 | 0.5093 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 53.77 | 84.90 | 98 | 6252 | 0.0157 | 0.0234 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 53.77 | 84.90 | 1220 | 6252 | 0.1951 | 0.5368 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 55.48 | 84.90 | 1073 | 6567 | 0.1634 | 0.4983 | MN20160318_Q02 | F07 |